Reference McAuley,J.B. McAuley .2014 .. " Journal of the Pediatric Infectious Diseases Society, 3(Suppl 1) : S30-S35.
Al-Malki S.E. .2020 ."Toxoplasmosis: stages of the protozoan life cycle and risk assessment in humans and animals for an enhanced awareness and an improved socio-economic status.". Saudi Journal of Biological Sciences, 11(1) : 962-969.
Montoya J.G. .2002 ."Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. " Journal of Infectious Diseases, 185(Suppl 1) : S73-S82.
Liu Q. .2015 ."Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. " Parasites & Vectors, 8 : 292-292.
Flegr J. .2014 ."Toxoplasmosis-a global threat: correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.". PLOS ONE, 0090203(3) : .
Ang Y.N. .2013 ."Multifactorial influences of childhood obesity.". Current Obesity Reports, 2 : 10-22.
Flores-Dorantes .2020 ."Environment and gene association with obesity and their impact on neurodegenerative and neurodevelopmental diseases." Frontiers in Neuroscience. , 00863 : 863.
Reeves G.M. .2013 ."A positive association between Toxoplasma gondii seropositivity and obesity. " Frontiers in Public Health, 00073 : 73.
Grundy S.M.,Biology Vascular .2004 ."Definition of metabolic syndrome." Arteriosclerosis, Thrombosis, and. , 0000(2) : 111245-e18.
Roberts C.K. .2013 ."Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.". Comprehensive Physiology, 3(1) : 1-58.
Jha B.K. .2023 ."Progress in understanding metabolic syndrome and knowledge of its complex pathophysiology. " Diabetology, 4(2) : 134-159.
Matsubayashi Y. .2022 ."Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex.". Cardiovascular Diabetology, 21 : 90.
Kassi E. .2011 ."Metabolic syndrome: definitions and controversies. " BMC Medicine, 9 : 1741.
Salem D.A. .2021 ."Association between Toxoplasma gondii infection and metabolic syndrome in obese adolescents: a possible immune-metabolic link. " Parasitology International, 102343 : 102343.
Zhou Z. .2019 ."The association between Toxoplasma gondii infection and risk of Parkinson's disease: a systematic review and meta-analysis." BioMed Research International. , : 8186017.
Molan A. .2020 ."The association between Toxoplasma gondii and type 2 diabetes mellitus: a systematic review and metaanalysis of human case-control studies.". Bulletin of the National Research Centre, 44 : 7.
Lin X.,Li H.,therapeutics. H. .2021 ."Obesity: epidemiology, pathophysiology, and. , 706978 : 706978.
Hruby A.,Hu F.B. .2015 ."The epidemiology of obesity: a big picture. " Pharmacoeconomics, 33(7) : 673-689.
Ginsberg H.N. and P.R.,MacCallum H.N. and P.R. .2008 ."The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. " Journal of Cardiometabolic Syndrome, 00044(2) : 4572-119.
Fahed G. .2022 ."Metabolic syndrome: updates on pathophysiology and management in 2021.". International Journal of Molecular Sciences, 23(2) : 786.
Halonen S.K.,Weiss L.M. .2013 ."Toxoplasmosis.". -444-53490-3, 114 : 00008-145.
Al-Halbousi Y.R.S.,Al-Warid H.S. .2024 ."Lipid profile parameters and adipokines among adolescents infected with toxoplasmosis.". Iraqi Journal of Science, 65(5) : 2410-2417.
Huang J. .2022 ."The association between Toxoplasma infection and mortality: the NHANES epidemiologic followup study. " Parasites & Vectors, 15 : 284.
Oz H.S. .2014 .. obesity and drug discovery." Pancreatic Disorders & Therapy, 4(2) : 138.
Shea-Donohue T. .2017 ."Parasites, nutrition, immune responses and biology of metabolic tissues.". Parasite Immunology, 39(5) : .
López-Ortega O. .2022 ."The immune response in adipocytes and their susceptibility to infection: a possible relationship with infectobesity.". International Journal of Molecular Sciences, 23(11) : 6154.